Bioverge

Early Stage

Bioverge is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life.

Analytics

Raised to Date: Raised: $688,037

Aggregate Commitments $

Platform

Netcapital

Start Date

05/14/2021

Close Date

01/13/2022

Min. Goal

$10,000

Max. Goal

$1,069,999

Min. Investment

$99

Security Type

Equity - Common

Funding Type

RegCF

Series

Pre-Seed

Pre-Money Valuation

$10,014,900

Rolling Commitments $

Status

Active

Reporting Date

12/05/2021

Days Remaining

39

% of Min. Goal

6,880%

% of Max. Goal

64%

Likelihood of Max
unlikely
Avg. Daily Raise

$3,356

Momentum
cool.svg
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

San Francisco, California

Industry

Financial & Insurance Products & Services

Tech Sector

Fintech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

Low

Business Type

Growth

Bioverge, with a post-money valuation of $11 million, is raising funds on NetCapital. It is an investment platform that funds entrepreneurs with the aim to transform healthcare. The platform allows both accredited and non-accredited investors to invest in healthcare startups and support them. Neil J. Littman and Rick Gibb founded Bioverge in 2017. The current crowdfunding round has a minimum raise of $10,000 and a maximum raise of $1,069,999, and the funds will be used for product development, sales and marketing, and general and administrative expenses. Bioverge has successfully closed 32 deals across 21 portfolio companies.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$68,795

$24,047

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-432,913

$-161,357

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$570,343

$266,383

Accounts Receivable

$7,034

$4,997

Total Assets

$975,622

$544,624

Short-Term Debt

$123,702

$123,702

Long-Term Debt

$1,363,520

$588,520

Total Liabilities

$1,487,222

$712,222

Financials as of: 05/14/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Bioverge 01/13/2022 Netcapital $10,014,900 $688,037 Equity - Common Active RegCF
Bioverge 05/13/2021 Netcapital $10,014,900 $0 Equity - Common Funded Test the Waters / RegCF
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Bioverge on NetCapital
$
Platform: Netcapital
Security Type: Equity - Common
Valuation: $10,014,900
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow Bioverge on NetCapital